Wellens J, Edmans M, Obolski U, McGregor CG, et al. Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease. Gut 2021 Dec 15. pii: gutjnl-2021-326312. doi: 10.1136/gutjnl-2021-326312.
PMID: 34911744